Digital strategies to improve help-seeking for youth at risk of psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create a Digital Laboratory to enhance help-seeking behaviors and speed up treatment initiation for youth aged 12-29 who are at Clinical High Risk for developing psychosis. By utilizing the Health Action Process Approach (HAPA) model, the study will analyze help-seeking patterns in 25,000 youth who screen positive for psychosis risk. It will employ Micro-Randomized Trials and a Sequential Multiple Assignment Randomized Trial to develop personalized strategies for advancing help-seeking and will link participants to local clinical care through a national network. The study seeks to establish effective thresholds for identifying clinical high risk online and to curate a large dataset of youth with CHR.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Ages 12-29 years
* Living within a 50-mile radius of a US based AMP-SCZ site
* Able to complete the English language PQ-B on MHA's screening platform

Where it's running

• Columbia University Irving Medical Center
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Michael Birnbaum, MD — Columbia University
• Study coordinator: Michael Birnbaum, MD
• Email: mlb2216@cumc.columbia.edu
• Phone: 212-523-2154

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Digital tools to help youth seek care sooner when at risk for psychosis

  This project will test personalized digital messages and online strategies to help people ages 12–29 who screen positive for psychosis risk find and start local care sooner.

  Recruiting Columbia University · New York, New York · NCT06774417

• State Representation in Early Psychosis 2

  This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.

  Recruiting at 2 sites University of Minnesota · Minneapolis, Minnesota and 1 other locations · NCT07834203

• BRAVE program to reduce violence risk in early psychosis

  A CBT-based program called BRAVE is tested with young adults in early psychosis to see if it is feasible and acceptable when added to usual care.

  Recruiting Howard University · Washington D.C., District of Columbia and 1 other locations · NCT07417904

• On Track for Wellness: a stepped-wedge program to boost sleep and activity in first-episode psychosis

  This program tests whether using Fitbit trackers, health education, and goal setting helps people with first-episode psychosis sleep better and move more.

  Recruiting University of Illinois Chicago · Chicago, Illinois · NCT07387705

• Adding ketones to antipsychotics in young adults with first episode psychosis

  This study tests whether giving exogenous ketones on top of antipsychotic treatment helps young adults experiencing a first episode of psychosis.

  Recruiting Université de Sherbrooke · Sherbrooke, Quebec · NCT07122531

• Add CBD to antipsychotic treatment for first-episode psychosis to see if it helps more than placebo

  This study tests whether adding cannabidiol (CBD) to ongoing antipsychotic treatment helps people with a first episode of psychosis who haven’t fully responded to their first antipsychotic, compared with a placebo.

  Recruiting at 2 sites Phase 3 University of Oxford · Vienna and 16 other locations · NCT06778564

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.